How exactly would you utilize ADT via leuprolide or bicalutamide with salvage RT post prostatectomy with PSA >0.5?
Answer from: Medical Oncologist at Academic Institution
The dilemma on the need for hormonal therapy in the salvage radiation setting after radical prostatectomy is a major one in current clinical practice, driven by the modest survival benefits seen in the RTOG 9601 trial with 2 years of bicalutamide (Shipley et al., PMID 28146658), but also follow up s...
Comments
Medical Oncologist at Stanford School of Medicine Would you consider bicalutamide over ADT if the pa...
Radiation Oncologist at Prostate Cancer Institute of America Hey @Ali R. Khaki.
In these patients, I have trie...
Radiation Oncologist at Lafayette Radiation Center Agree with the above. Decipher is the future with ...
Answer from: Radiation Oncologist at Community Practice
Excellent and thorough answer by @Andrew J. Armstrong above. I would also just add the results of RTOG 0534/ [SPPORT] as corroboration, which looked at the benefit of adding 4-6 months of STADT using an anti-androgen + LHRH agonist in 2 of the three arms: Prostate bed RT alone, prostate bed RT + STA...
Would you consider bicalutamide over ADT if the pa...
Hey @Ali R. Khaki. In these patients, I have trie...
Agree with the above. Decipher is the future with ...